Related references
Note: Only part of the references are listed.Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study
Alexis Ogdie et al.
EUROPEAN HEART JOURNAL (2018)
Safety and Efficacy of Baricitinib Through 128 Weeks in an Open-label, Longterm Extension Study in Patients with Rheumatoid Arthritis
Edward C. Keystone et al.
JOURNAL OF RHEUMATOLOGY (2018)
Comparative efficacy and safety of baricitinib 2 mg and 4 mg in patients with active rheumatoid arthritis A Bayesian network meta-analysis of randomized controlled trials
Y. H. Lee et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2018)
Analysis of Spontaneous Postmarket Case Reports Submitted to the FDA Regarding Thromboembolic Adverse Events and JAK Inhibitors
Abril Verden et al.
DRUG SAFETY (2018)
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study
Maxime Dougados et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
A review of tofacitinib efficacy in rheumatoid arthritis patients who have had an inadequate response or intolerance to methotrexate
Roy Fleischmann
EXPERT OPINION ON PHARMACOTHERAPY (2017)
Efficacy of baricitinib in the treatment of rheumatoid arthritis
Christophe Richez et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
Safety of biologic DMARDs in RA patients in real life: A systematic literature review and meta-analyses of biologic registers
Maite de la Forest Divonne et al.
JOINT BONE SPINE (2017)
Treating active rheumatoid arthritis with Janus kinase inhibitors
David L. Scott et al.
LANCET (2017)
Pathogenetic insights from the treatment of rheumatoid arthritis
Iain B. McInnes et al.
LANCET (2017)
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
Daniella M. Schwartz et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
The emerging safety profile of JAK inhibitors in rheumatic disease
Kevin L. Winthrop
NATURE REVIEWS RHEUMATOLOGY (2017)
Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
Peter C. Taylor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study
Akbar K. Waljee et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study
Akbar K. Waljee et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis
Michael E. Weinblatt et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment
Roy Fleischmann et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Baricitinib in rheumatoid arthritis: evidence-to-date and clinical potential
Bindee Kuriya et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2017)
Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of The EULAR recommendations for the management of rheumatoid arthritis
Katerina Chatzidionysiou et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
Shubhasree Banerjee et al.
DRUGS (2017)
Paracetamol: not as safe as we thought? A systematic literature review of observational studies
Emmert Roberts et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-week, Double-blind, Randomized Placebo-controlled Study
Yoshiya Tanaka et al.
JOURNAL OF RHEUMATOLOGY (2016)
Baricitinib in Patients with Refractory Rheumatoid Arthritis
Mark C. Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A Phase IIb Study of ABT-494, a Selective JAK-1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Therapy
Joel M. Kremer et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Behcet's syndrome: pulmonary vascular disease
Emire Seyahi et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
Epidemiology of venous thromboembolism
John A. Heit
NATURE REVIEWS CARDIOLOGY (2015)
Comparative efficacy and safety of tofacitinib, with or without methotrexate, in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials
Young Ho Lee et al.
RHEUMATOLOGY INTERNATIONAL (2015)
Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: A study among a U.S. cohort of commercial insurance enrollees
Hussain R. Yusuf et al.
THROMBOSIS RESEARCH (2015)
Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate
Edward C. Keystone et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Increased Rheumatoid Factor and Deep Venous Thrombosis: 2 Cohort Studies of 54628 Individuals from the General Population
Christine L. Meyer-Olesen et al.
CLINICAL CHEMISTRY (2015)
Non-steroidal anti-inflammatory drugs and risk of venous thromboembolism: a systematic review and meta-analysis
Patompong Ungprasert et al.
RHEUMATOLOGY (2015)
Risk Factors of Pulmonary Thrombosis/Embolism in Nephrotic Syndrome
Yihe Yang et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2014)
Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis
Patompong Ungprasert et al.
CLINICAL RHEUMATOLOGY (2014)
A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases
Jason J. Lee et al.
ARTHRITIS RESEARCH & THERAPY (2014)
The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study
Hyon K. Choi et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Use of Glucocorticoids and Risk of Venous Thromboembolism A Nationwide Population-Based Case-Control Study
Sigrun A. Johannesdottir et al.
JAMA INTERNAL MEDICINE (2013)
Noncardiac vascular disease in rheumatoid arthritis: Increase in venous thromboembolic events?
A. Kirstin Bacani et al.
ARTHRITIS AND RHEUMATISM (2012)
Thromboembolic events and anti-tumor necrosis factor therapies
P. L. Masson
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis and Association With Disease Duration and Hospitalization
Marie E. Holmqvist et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register
Rebecca Davies et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Venous and Arterial Thromboembolic Events in Adalimumab-Treated Patients With Antiadalimumab Antibodies
L. A. Korswagen et al.
ARTHRITIS AND RHEUMATISM (2011)
Risk of venous thromboembolism with rheumatoid arthritis
Fadi Matta et al.
THROMBOSIS AND HAEMOSTASIS (2009)
Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom
Consuelo Huerta et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations
KP Liang et al.
ARTHRITIS AND RHEUMATISM (2006)
Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years
AYN Lim et al.
RHEUMATOLOGY (2005)
The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions
AJ Kinder et al.
RHEUMATOLOGY (2005)
Pulmonary thrombosis in adults with Eisenmenger syndrome
CK Silversides et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
The epidemiology of venous thromboembolism
RH White
CIRCULATION (2003)
Methotrexate and mortality in patients with rheumatoid arthritis:: a prospective study
HK Choi et al.
LANCET (2002)
Share Paper
